Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

Rhea-AI Summary

Lucid Diagnostics (Nasdaq: LUCD), a commercial-stage cancer prevention medical diagnostics company and subsidiary of PAVmed (Nasdaq: PAVM), has scheduled a business update conference call and webcast for May 14, 2025, at 8:30 AM ET.

Key highlights of the upcoming call:

• Chairman and CEO Lishan Aklog will present a business update and discuss the company's operations and growth strategy
• CFO Dennis McGrath will review first quarter 2025 financial results
• U.S. participants can dial 1-800-836-8184
• International callers should use 1-646-357-8785

The webcast will be accessible through the investor relations section at luciddx.com. A 30-day replay will be available on the same platform following the call. Participants should reference "Lucid Diagnostics Business Update" when joining.

Positive

• Commercial-stage cancer prevention medical diagnostics company
• Subsidiary of publicly traded company PAVmed (PAVM)
• Senior executives (CEO and CFO) directly presenting business updates

Negative

• None.

Conference Call and Webcast at 8:30 AM Eastern Time

NEW YORK, April 30, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business update conference call and webcast on Wednesday, May 14, 2025, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update, including an overview of the Company's operations and continued growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's first quarter 2025 financial results.

The webcast will be available at the investor relations section of the Company's website at luciddx.com. Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "Lucid Diagnostics Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at luciddx.com.

About Lucid Diagnostics
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard^® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck^® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.

For more information, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-hold-a-business-update-conference-call-and-webcast-on-may-14-2025-302442320.html

SOURCE Lucid Diagnostics

FAQ

When is Lucid Diagnostics (LUCD) Q1 2025 earnings call scheduled?

Lucid Diagnostics (LUCD) will hold its Q1 2025 earnings call on Wednesday, May 14, 2025, at 8:30 AM Eastern Time.

How can investors join Lucid Diagnostics (LUCD) May 14 conference call?

U.S. investors can dial 1-800-836-8184, while international callers should use 1-646-357-8785. All callers should mention 'Lucid Diagnostics Business Update' to join.

Where can I find the replay of LUCD's May 14 2025 business update?

The replay will be available for 30 days on Lucid Diagnostics' investor relations website at luciddx.com.

What topics will be covered in LUCD's May 14 2025 business update?

The call will cover Lucid's Q1 2025 financial results, business operations update, and continued growth strategy, presented by CEO Dr. Lishan Aklog and CFO Dennis McGrath.

How can I watch the webcast of Lucid Diagnostics May 2025 earnings call?

The webcast will be accessible through the investor relations section of Lucid Diagnostics' website at luciddx.com.